European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
01 6Polpharma
02 3Dr. Reddy's Laboratories
03 5Pharmathen SA
04 82care4
05 16Abacus Medicine
06 4Actavis Inc
07 8Ajanta Pharma Limited
08 4Alembic Pharmaceuticals Limited
09 3Alter Laboratories Sa
10 5Amdipharm Mercury Company Limited
11 4Amneal Pharmaceuticals
12 4CLONMEL HLTHCARE
13 4CSPC Pharmaceutical Group
14 3Centocor
15 3Cinfa
16 5Ebb Medical
17 4Everest Life Sciences
18 12Exeltis
19 6Genericon Pharma Ges.M.B.H.
20 4Helsinn Advanced Synthesis
21 6Heumann
22 8Inventia Healthcare Limited
23 86Janssen-Cilag
24 30Johnson & Johnson Innovative Medicine
25 3Kern Pharma S.L.
26 9Krka
27 5Laboratorios Liconsa
28 4Lupin Ltd
29 3Medartuum
30 8Mepha Pharma
31 11Neuraxpharm
32 8ORIFARM GROUP AS
33 3Pantson Pharma Pvt. Limited
34 2RELIANCE FORMULATION PVT. LTD
35 4RK Pharma
36 12STADA Arzneimittel
37 21Sandoz B2B
38 5Spirig Healthcare
39 4Sun Pharmaceutical Industries Limited
40 6TAD Pharma
41 19Teva Pharmaceutical Industries
42 6Uab Bijon Medica
43 4Unichem Laboratories Limited
44 12Viatris
45 15Zentiva
46 4Zydus Pharmaceuticals
47 16Blank
01 20ER Tablet
02 10Extended Release Tablet
03 9Extended Release Tablets
04 42Extended-Release Tablet
05 4INJ
06 90Injectable Solution
07 3LP Tablet
08 6Modified Release Tablet
09 1Paliperidone 100Mg 1 Unit Parenteral Use Rp
10 1Paliperidone 150Mg 1 Unit Parenteral Use Rp
11 1Paliperidone 3Mg 28 Combined Oral Use Rp
12 1Paliperidone 50Mg 1 Unit Parenteral Use Rp
13 1Paliperidone 6Mg 28 Combined Oral Use Rp
14 1Paliperidone 75Mg 1 Unit Parenteral Use Rp
15 1Paliperidone 9Mg 28 Combined Oral Use Rp
16 6Prolonged Release Suspension For Injection In Pre-Filled Syringe
17 8Prolonged Release Tablet
18 8Prolonged-Release Injectable Suspension
19 19Prolonged-Release Suspension For Injection
20 91Suspension For Injection
21 3TAB
22 3TABLET (EXTENDED-RELEASE)
23 4TABLET, EXTENDED RELEASE; ORAL
24 56TABLET, EXTENDED RELEASE;ORAL
25 22Tablet
26 14Blank
01 28Allowed
02 158Approved
03 4Authorised
04 36Authorized
05 4Countries Registered In: US (Filed 2012)
06 13DISCN
07 19Deregistered
08 4Generic
09 7Originator
10 35Prescription
11 43RX
12 12Registered in US
13 4US (Filed 2012)
14 58Blank
01 4Byannli
02 6Dnepr
03 16INVEGA
04 3Inpalix
05 30Invega
06 1Invega 3Mg
07 1Invega 6Mg
08 1Invega 9Mg
09 2Invega Hafyera
10 5Invega Sustenna
11 4Invega Trinza
12 6Invega®
13 9Mopetia
14 11Niapelf
15 1PALICALM ER 3
16 1PALICALM ER 6
17 3PALIPERIDON KRKA
18 51PALIPERIDONE
19 3PALIPERIDONE SANDOZ
20 3PALIPERIDONE TEVA
21 6Paliperidon Heumann
22 3Paliperidon Krka
23 35Paliperidon Teva
24 6Paliperidon Zentiva
25 3Paliperidona Cinfa
26 3Paliperidona Ratiopharm
27 3Paliperidona Sandoz
28 4Paliperidone 2Care4
29 3Paliperidone Alter
30 6Paliperidone Bijon
31 4Paliperidone Clonmel
32 3Paliperidone Ebb
33 6Paliperidone Exeltis
34 6Paliperidone Genericon
35 6Paliperidone Janssen
36 6Paliperidone Janssen-Cilag International
37 5Paliperidone Liconsa
38 9Paliperidone Sandoz
39 1Paliperidone Spirig HC retard
40 4Paliperidone Spirig HC retard
41 6Paliperidone Stada
42 3Paliperidone Tad
43 4Paliperidone Teva
44 6Paliperidone Viatris
45 6Paliperidone Viatris Pharma
46 1Paliperidone-Mepha
47 4Paliperidone-Mepha im
48 3Paliperidone-Mepha retard
49 9Palmeux
50 6Parnido
51 6Poltraxin
52 6Pratyria
53 6Psylipax
54 3Teva Paliperidon
55 8Trevicta
56 4Trevicta
57 1XEPLION 100 mg/1,0 ml
58 1XEPLION 150 mg/1,50 ml
59 1XEPLION 50 mg/0,50 ml
60 1XEPLION 75 mg/0,75 ml
61 21Xeplion
62 4Xeplion®
63 32Blank
01 14Australia
02 3Canada
03 32Estonia
04 5Greece
05 25India
06 20Italy
07 4Malta
08 10Moldova
09 7South Africa
10 36Spain
11 177Sweden
12 28Switzerland
13 60USA
14 4Blank
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 100mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000179
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 100mg, 150mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20230216000134
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 150mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000186
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 25mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000148
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 50mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000155
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 75mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000162
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 9MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 12MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Pratyria
Dosage Form : Suspension For Injection
Dosage Strength : 100mg
Packaging :
Approval Date : 24/04/2024
Application Number : 20221221000219
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Pratyria
Dosage Form : Suspension For Injection
Dosage Strength : 150mg
Packaging :
Approval Date : 24/04/2024
Application Number : 20221221000226
Regulatory Info : Approved
Registration Country : Sweden
